# Lesaka Technologies Inc: overview

LSAK · Nasdaq · CIK 1041514 · [Financials](/sectors/financials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/lsak.md) · [Financials](/companies/lsak/financials.md) · [Filings](/companies/lsak/filings.md) · [Insiders](/companies/lsak/insiders.md)

Latest reported revenue: [$188.3m](/filings/0001562762-26-000104.md) for Q4 FY2026, three months to 2026-06-30, from the 10-K filed Sep 9, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001562762-26-000104).

## Last eight quarters

| Line item | Unit | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [154](/filings/0001562762-25-000264.md) | [176](/filings/0001562762-26-000015.md) | [161](/filings/0001562762-26-000058.md) | [168 d](/filings/0001562762-26-000104.md) | [171](/filings/0001562762-25-000264.md) | [179](/filings/0001562762-26-000015.md) | [183](/filings/0001562762-26-000058.md) | [188 d](/filings/0001562762-26-000104.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(0.0%)](/filings/0001562762-25-000264.md) | [0.3%](/filings/0001562762-26-000015.md) | [0.2%](/filings/0001562762-26-000058.md) | [(17.0%) d](/filings/0001562762-26-000104.md) | [0.2%](/filings/0001562762-25-000264.md) | [1.2%](/filings/0001562762-26-000015.md) | [2.2%](/filings/0001562762-26-000058.md) | [3.4% d](/filings/0001562762-26-000104.md) |
| Net margin | % | [(3.0%)](/filings/0001562762-25-000264.md) | [(18.4%)](/filings/0001562762-26-000015.md) | [(13.8%)](/filings/0001562762-26-000058.md) | [(18.6%) d](/filings/0001562762-26-000104.md) | [(2.5%)](/filings/0001562762-25-000264.md) | [2.0%](/filings/0001562762-26-000015.md) | [0.3%](/filings/0001562762-26-000058.md) | [1.7% d](/filings/0001562762-26-000104.md) |
| Diluted EPS | $ per share | [(0.07)](/filings/0001562762-25-000264.md) | [(0.40)](/filings/0001562762-26-000015.md) | [(0.28)](/filings/0001562762-26-000058.md) | not reported | [(0.05)](/filings/0001562762-25-000264.md) | [0.04](/filings/0001562762-26-000015.md) | [0.01](/filings/0001562762-26-000058.md) | not reported |
| Free cash flow | $m | [(8.1)](/filings/0001562762-25-000264.md) | [(15.5)](/filings/0001562762-26-000015.md) | [7.8](/filings/0001562762-26-000058.md) | [(10.6) d](/filings/0001562762-26-000104.md) | [4.9](/filings/0001562762-25-000264.md) | [(14.8)](/filings/0001562762-26-000015.md) | [34.2](/filings/0001562762-26-000058.md) | [7.5 d](/filings/0001562762-26-000104.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-06-30) | FY2023 (2023-06-30) | FY2024 (2024-06-30) | FY2025 (2025-06-30) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [223](/filings/0001562762-24-000222.md) | [528](/filings/0001562762-25-000245.md) | [564](/filings/0001562762-26-000104.md) | [660](/filings/0001562762-26-000104.md) | [722](/filings/0001562762-26-000104.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(18.1%)](/filings/0001562762-24-000222.md) | [(2.9%)](/filings/0001562762-25-000245.md) | [0.5%](/filings/0001562762-26-000104.md) | [(4.2%)](/filings/0001562762-26-000104.md) | [1.8%](/filings/0001562762-26-000104.md) |
| Net margin | % | [(19.7%)](/filings/0001562762-24-000222.md) | [(6.6%)](/filings/0001562762-26-000013.md) | [(3.3%)](/filings/0001562762-26-000104.md) | [(13.8%)](/filings/0001562762-26-000104.md) | [0.4%](/filings/0001562762-26-000104.md) |
| Diluted EPS | $ per share | [(0.75)](/filings/0001562762-24-000222.md) | [(0.56)](/filings/0001562762-25-000245.md) | [(0.29)](/filings/0001562762-26-000104.md) | [(1.19)](/filings/0001562762-26-000104.md) | [0.03](/filings/0001562762-26-000104.md) |
| Free cash flow | $m | [(41.8)](/filings/0001562762-24-000222.md) | [(15.7)](/filings/0001562762-25-000245.md) | [16.1](/filings/0001562762-26-000104.md) | [(26.3)](/filings/0001562762-26-000104.md) | [31.8](/filings/0001562762-26-000104.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/lsak/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $25.5m | 5,135,127 |  | Added +5,515 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $25.1m | 5,053,010 |  | Reduced −23,837 |
| [Rathbones Group PLC](/funds/1351991.md) | 2026-06-30 | $18.2m | 3,657,420 |  | Added +13,000 |
| [Hosking Partners LLP](/funds/1650135.md) | 2026-06-30 | $13.5m | 2,724,153 |  | Reduced −48,509 |
| [Potomac Capital Management, Inc.](/funds/1418746.md) | 2026-06-30 | $7.5m | 1,515,000 |  | Added +402,758 |
| [Kingsway Capital Partners Ltd](/funds/2145813.md) | 2026-06-30 | $4.6m | 919,888 |  | Not compared |
| [DEUTSCHE BANK AG\\](/funds/948046.md) | 2026-06-30 | $2.2m | 439,307 |  | Added +340,344 |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $2.0m | 400,414 |  | Added +326,597 |
| [BARCLAYS PLC](/funds/312069.md) | 2026-06-30 | $1.2m | 250,350 |  | Reduced −17,573 |
| [INTREPID FAMILY OFFICE LLC](/funds/1596197.md) | 2026-06-30 | $1.2m | 250,000 |  | Unchanged |

## Recent filings

[All 958 filings](/companies/lsak/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-02 | 20:05 ET | [DEF 14A](/filings/0001562762-26-000119.md) | Proxy statement, period 2026-11-18 | 0001562762-26-000119 |
| 2026-09-29 | 23:15 ET | [SCHEDULE 13D/A](/filings/0001193125-26-407970.md) | Ownership report, active investor, amended | 0001193125-26-407970 |
| 2026-09-29 | 20:07 ET | [8-K](/filings/0001062993-26-005108.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001062993-26-005108 |
| 2026-09-14 | 20:05 ET | [8-K](/filings/0001062993-26-004931.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001062993-26-004931 |
| 2026-09-09 | 20:41 ET | [8-K](/filings/0001062993-26-004866.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001062993-26-004866 |
| 2026-09-09 | 20:39 ET | [10-K](/filings/0001562762-26-000104.md) | Annual report, period 2026-06-30 | 0001562762-26-000104 |
| 2026-08-03 | 13:48 ET | [8-K](/filings/0001062993-26-003974.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001062993-26-003974 |
| 2026-07-30 | 20:05 ET | [8-K](/filings/0001062993-26-003930.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001062993-26-003930 |
| 2026-07-02 | 20:19 ET | [DEF 14A](/filings/0001062993-26-003502.md) | Proxy statement, period 2026-08-03 | 0001062993-26-003502 |
| 2026-06-17 | 01:47 ET | [SCHEDULE 13D/A](/filings/0001193125-26-274718.md) | Ownership report, active investor, amended | 0001193125-26-274718 |

## Latest annual report

[Form 10-K for the fiscal year ended Jun 30, 2026](/filings/0001562762-26-000104.md), filed Sep 9, 2026.

## Forecast league

Q1 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/d3ec319a-0d42-4d10-a270-f53cff7b7af0)

## About the filer

- CIK: 1041514
- Tickers: LSAK
- Exchange: Nasdaq
- SIC code: 6099 Functions Related To Depository Banking, NEC
- State of incorporation: FL
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.